Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline for post-stroke emotionalism
ISRCTN67104246Phase 3Recruiting
- Sponsor
- Norfolk and Norwich University Hospitals NHS Foundation Trust
- Start
- Jan 2025
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in Post-stroke emotionalism (PSE) comparing Sertraline with Placebo (2 arms). Primary endpoint: Change in post-stroke emotionalism symptoms at 6 months. Started Jan 2025; status: recruiting.
02
Drugs
sertraline
03
Conditions
Post-stroke emotionalism (PSE)
Beyond the preview
Go deeper on ISRCTN67104246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN67104246.